Elevance Health has paid $342 million to the Centers for Medicare & Medicaid Services in the midst of a billing investigation. The payment comes as the agency threatened to ban new enrollments in the company’s Medicare Advantage plans. This marks a significant escalation in the government's oversight of private Medicare plans.
Medicare Advantage plans, which are run by private insurers, have faced growing scrutiny for alleged overbilling. Regulators suspect that some companies have inflated diagnoses to receive higher payments. Elevance's payment appears aimed at resolving some of these disputed charges.
KFF Health News reported the $342 million figure, attributing it to CMS documents. The exact nature of the billing issues has not been fully disclosed. This is one of the larger payments made by a single insurer in a probe context.
The threat to bar new enrollments could significantly impact Elevance's growth in a lucrative market. Other insurers may face similar actions if the probe widens. The move signals that CMS is willing to use its enforcement powers aggressively.
Critics argue that such payments may not address systemic billing problems. Consumer advocates say more transparency in Medicare Advantage billing is needed to prevent future discrepancies.